RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION. This article is written for laboratory researchers about analytical methods used to characterize research compounds. Nothing here is medical advice.
Why purity verification matters in peptide research
In laboratory research, the purity of a synthetic peptide directly affects experimental reproducibility. Impurities — deletion sequences, truncated fragments, residual protecting groups, or counter-ions — can introduce signaling artifacts in sensitive biological assays. A peptide that is 99% pure by one method may still carry the wrong sequence, which is why identity confirmation and purity measurement are treated as two separate, complementary questions.
Reversed-phase HPLC: measuring purity
Reversed-phase high-performance liquid chromatography (RP-HPLC) is the standard method for peptide purity assessment. The sample is separated on a C18 column using a gradient of increasing organic solvent (typically acetonitrile with 0.1% formic acid or TFA in water), with UV detection at 214 nm and 280 nm. Purity is calculated as the main peak’s area relative to the total area of all peaks. Closely eluting impurities such as deletion sequences — often slightly less hydrophobic than the full-length peptide — are resolved by shallow gradients optimized for the target sequence.
Electrospray mass spectrometry: confirming identity
Mass spectrometry confirms what the sample is. Electrospray ionization (ESI) is the standard ionization method for peptides: a soft technique that preserves the molecular ion and generates multiply charged ions (e.g., [M+2H]²⁺, [M+3H]³⁺), allowing large peptides to be analyzed within a typical m/z range. The observed molecular weight is compared against the theoretical weight calculated from the target sequence. A match within the instrument’s mass accuracy — typically ±0.5 Da for single-quadrupole instruments, ±0.01 Da for high-resolution Orbitrap or Q-TOF systems — confirms identity. Discrepancies indicate sequence errors, modifications, or incorrect product.
The complementary rule
HPLC confirms how pure the sample is; MS confirms what the sample is. Both tests are required for complete analytical verification. A complete characterization package may also include amino acid analysis (AAA) for sequence composition, endotoxin testing via the Limulus Amebocyte Lysate (LAL) assay, net peptide content determination (quantifying actual peptide weight versus moisture, counter-ions, and non-peptide components), and residual solvent analysis.
How to read a peptide Certificate of Analysis
A credible COA should show: the analytical methods used (HPLC conditions, MS instrument type), the measured purity percentage, the observed versus theoretical mass, the lot or batch number, the test date, and the testing laboratory. Compare the lot number on the COA to the vial label, check that the mass match is within the stated instrument accuracy, and confirm the chromatogram shows a single dominant peak.
References
1. HPLC & Mass Spectrometry: Peptide Purity Verification Methods — https://instantpeptides.com/blog/peptide-purity-testing-hplc-mass-spec
2. Synthetic peptide enantiomeric purity analysis by chiral HPLC-ESI-MS/MS (American Chemical Society) — https://acs.digitellinc.com/p/s/synthetic-peptide-enantiomeric-purity-analysis-by-chiral-high-performance-liquid-chromatography-electrospray-ionization-mass-spectrometry-526553
All compounds discussed are for laboratory research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.